Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 100

Sort by

Sort Order Select

Journal Articles

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Xiaowu Wu, MD MSc, Daniel N. Darlington, PhD, Josue Garciamarcano, Bin Liu, BS, Jeffrey D Keesee, BS, James Bynum, PhD, Andrew P. Cap, MD PhD

Blood (2019) 134 (Supplement_1): 2345.

https://doi.org/10.1182/blood-2019-130278

Published: 2019

Journal Articles

Super factor Va, an Engineered Factor V Molecule, Effectively Reduces Bleeding and Acute Coagulopathy in Mouse Models of Trauma and Shock

Bilgimol Chumappumkal Joseph, PhD, Laurent O Mosnier, Annette von Drygalski, MD PharmD

Blood (2019) 134 (Supplement_1): 1101.

https://doi.org/10.1182/blood-2019-124433

Published: 2019

Journal Articles

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Blood (2019) 134 (Supplement_1): 1130.

https://doi.org/10.1182/blood-2019-124234

Published: 2019

Journal Articles

Prevention of Bleeding-Induced Vascular Abnormalities in the Hemophilic Mouse Joint By Increasing TAFI Levels or Inhibiting uPA Activity

Tine Wyseure, PhD, Niels Behrendt, Annette von Drygalski, MD PharmD, Laurent O Mosnier

Blood (2019) 134 (Supplement_1): 158.

https://doi.org/10.1182/blood-2019-128723

Published: 2019

Journal Articles

Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy

Alona A. Merkulova, MA, Steven C. Mitchell, MA, Sergei Merkulov, PhD, Alisa S. Wolberg, PhD, Neerman-Arbez Marguerite, PhD, Alvin H. Schmaier, MD

Blood (2019) 134 (Supplement_1): 4934.

https://doi.org/10.1182/blood-2019-131319

Published: 2019

Journal Articles

Immediate and Long-Term Outcomes Following Orthopedic Procedures in Patients with Hemophilia: A Three-Decade Retrospective Review

CHU Yang Lin, MD, Haowei Sun, MD

Blood (2019) 134 (Supplement_1): 5874.

https://doi.org/10.1182/blood-2019-123207

Published: 2019

Journal Articles

Synthetic Platelets for Treatment of Traumatic Hemorrhage and Thrombocytopenia

Anirban Sen Gupta, PhD

Blood (2019) 134 (Supplement_1): SCI-37.

https://doi.org/10.1182/blood-2019-121079

Published: 2019

Journal Articles

Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Ying Ling, BMSc, MD, Filomena Meffe, MD MSc, Deborah Robertson, MD, Jessica Petrucci, MSc, Georgina Floros, RN, Paula D. James, MD, Jeffrey Mosko, MD MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc

Blood (2019) 134 (Supplement_1): 5868.

https://doi.org/10.1182/blood-2019-122521

Published: 2019

Journal Articles

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Berardino Pollio, Maria Messina, Irene Ricca, Mauro Pagliarino, Ugo Ramenghi, MD, Antonio Coppola, Anna Castiglione, Giovannino Ciccone, Teresa Ceglie, Anna Mondino, Paolo Tavormina, Claudia Linari

Blood (2019) 134 (Supplement_1): 2400.

https://doi.org/10.1182/blood-2019-130023

Published: 2019

Journal Articles

Successful Treatment of Mucosal Bleeding with Tranexamic Acid in Pediatric Patients with Hemostatic Disorders

Hisaya Nakadate, MD PhD, Akira Ishiguro, MD PhD, Atsushi Sakamoto, MD

Blood (2019) 134 (Supplement_1): 4902.

https://doi.org/10.1182/blood-2019-129360

Published: 2019

Journal Articles

Assessment of Emicizumab-Driven Clot Stability in Hemophilia a Model

Kenichi Ogiwara, MD PhD, Hiroki Horiuchi, Keiji Nogami, MD PhD, Takehisa Kitazawa, DVM, Midori Shima, MD PhD

Blood (2018) 132 (Supplement 1): 2478.

https://doi.org/10.1182/blood-2018-99-118379

Published: 2018

Journal Articles

Impact of Perioperative Tranexamic Acid on Risk of Bleeding in Total Hip and Knee Arthroplasty: An Analysis of the Epcat II Data

Sudeep P Shivakumar, MD BSc, Daniel E Singer, MD MA, Steve Doucette, David R. Anderson, MD

Blood (2018) 132 (Supplement 1): 2487.

https://doi.org/10.1182/blood-2018-99-119189

Published: 2018

Journal Articles

Hemostatic Effect of the Combination of Factor VIII Concentrate with Tranexamic Acid (TXA) in the Prophylactic Setting in Severe Hemophilia a

Maissaa Janbain, MD, Nathalie Enjolras, PhD, Jean-Claude Bordet, Radu Bolbos, Cindy A. Leissinger, MD, Yesim Dargaud, MD PhD

Blood (2018) 132 (Supplement 1): 2490.

https://doi.org/10.1182/blood-2018-99-119407

Published: 2018

Journal Articles

Recombinant Activated Coagulation Factor VII (rFVIIa) for Treatment of the Tracheobronchial Bleeding in Mechanically Ventilated (MV) Thrombocytopenic Patients (pts)

Gennadii M. Galstian, Olesya A. Polevodova, MD, Vladimir Yu. Zorenko, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2018) 132 (Supplement 1): 2446.

https://doi.org/10.1182/blood-2018-99-115685

Published: 2018

Journal Articles

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Treated with Rivaroxaban or Apixaban Compared to Warfarin Presenting with Major Bleeding

Deepa Jayakody Arachchillage, MD MRCP, FRCPath, Sharon Alavian, Jessica Griffin, MRCP, Kamala Gurung, MRCP, Richard Syzdlo, PhD, Nilanthi Karawitage, Michael Laffan, DM, FRCP, FRCPath

Blood (2018) 132 (Supplement 1): 2535.

https://doi.org/10.1182/blood-2018-99-116432

Published: 2018

Journal Articles

Prothrombin Complex Concentrate Is Safe and Effective for Achieving Hemostasis in the Setting of Urgent Surgery for Patients Treated with Direct Xa Inhibitors

Merav Barzilai, MD, Ilya Kirgner, MD, Arza Steimatzky, MD, Dalit Salzer Gotler, MD, Yulia Belnick, MD, Irit Avivi, MD, David Varon, MD, Adi Shacham, MD, Vered Yahalom, MD, Sigal Nakav, PhD, Ethan Yussim, MD, Gil Bahar, MD, Uri Rozovski, Galia Spectre, MD PhD

Blood (2018) 132 (Supplement 1): 2541.

https://doi.org/10.1182/blood-2018-99-117378

Published: 2018

Journal Articles

Comparison between Our Results in the Maturity Assessment Patient Blood Management (MAPBM) Project and Other 34 National Hospitals

Ana Belén Ortega López, Estefanía Morente Constantin, Pablo Romero Garcia, Maria Almudena Garcia Ruiz, Encarnación Moreno Abril, Manuel Jurado, MD PhD

Blood (2018) 132 (Supplement 1): 5081.

https://doi.org/10.1182/blood-2018-99-113082

Published: 2018

Journal Articles

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Sajida Kazi, MRCP, FRCPATH, Ann Kinga Malinowski, MD MSc, FRCSC, Clare Whitehead, Kevin H. M. Kuo, MDMSc, FRCPC, Lynda Harrington, Nancy Watts, Chen Wang, MD PhD FRCPC, Nadine Shehata, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 5077.

https://doi.org/10.1182/blood-2018-99-114949

Published: 2018

Journal Articles

Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study

Spero R Cataland, MD, Marie Scully, MD MRCP, FRCPath, Flora Peyvandi, MD PhD, Paul Coppo, MD PhD, Paul Knöbl, MD PhD, Johanna A. Kremer Hovinga, MD Prof, Ara Metjian, MD, Javier De La Rubia, MD, Katerina Pavenski, MD, Jessica Minkue, Rui Passos Sousa, MD MSc, Filip Callewaert, PhD, Hilde De Winter, MD

Blood (2018) 132 (Supplement 1): 1142.

https://doi.org/10.1182/blood-2018-99-112179

Published: 2018

Journal Articles

Transfusion Practice Following Intracranial Hemorrhage in Acute Leukemia: An Institutional Review

Shannon Nixon, NP, Dawn Maze, MD FRCPC, MSc, Eshetu G Atenafu, MSc, P.Stat, Danielle Brandys, MN NP, Cindy Susan Murray, MN NP, Suzanne Rowland, MSN NP, Mary Clementine Doherty, MN NP, Amanda Wolfe, BScPharm, RPh, ACPR, Benjamin YM Kwan, MD FRCPC, Eugene Yu, MD FRCPC, Breanne Lechner, BSc, MDc), Lani Lieberman, MD FRCPC

Blood (2018) 132 (Supplement 1): 4740.

https://doi.org/10.1182/blood-2018-99-112718

Published: 2018

NARROW

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Super factor Va, an Engineered Factor V Molecule, Effectively Reduces Bleeding and Acute Coagulopathy in Mouse Models of Trauma and Shock

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Prevention of Bleeding-Induced Vascular Abnormalities in the Hemophilic Mouse Joint By Increasing TAFI Levels or Inhibiting uPA Activity

Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy

Immediate and Long-Term Outcomes Following Orthopedic Procedures in Patients with Hemophilia: A Three-Decade Retrospective Review

Synthetic Platelets for Treatment of Traumatic Hemorrhage and Thrombocytopenia

Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding

Perioperative Bleeding Risk Assessment in a Cohort of Children with Low Levels of Von Willebrand Factor

Successful Treatment of Mucosal Bleeding with Tranexamic Acid in Pediatric Patients with Hemostatic Disorders

Assessment of Emicizumab-Driven Clot Stability in Hemophilia a Model

Impact of Perioperative Tranexamic Acid on Risk of Bleeding in Total Hip and Knee Arthroplasty: An Analysis of the Epcat II Data

Hemostatic Effect of the Combination of Factor VIII Concentrate with Tranexamic Acid (TXA) in the Prophylactic Setting in Severe Hemophilia a

Recombinant Activated Coagulation Factor VII (rFVIIa) for Treatment of the Tracheobronchial Bleeding in Mechanically Ventilated (MV) Thrombocytopenic Patients (pts)

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Treated with Rivaroxaban or Apixaban Compared to Warfarin Presenting with Major Bleeding

Prothrombin Complex Concentrate Is Safe and Effective for Achieving Hemostasis in the Setting of Urgent Surgery for Patients Treated with Direct Xa Inhibitors

Comparison between Our Results in the Maturity Assessment Patient Blood Management (MAPBM) Project and Other 34 National Hospitals

Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor

Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study

Transfusion Practice Following Intracranial Hemorrhage in Acute Leukemia: An Institutional Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only